Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients With FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review
Cancers - Switzerland
doi 10.3390/cancers11070981
Full Text
Open PDFAbstract
Available in full text
Date
July 13, 2019
Authors
Publisher
MDPI AG